Global Mucoadhesive Oral Film Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Mucoadhesive Oral Film Market Research Report 2024
Oral drug delivery is the most common route of drug administration. Nevertheless, there are some important limitations that reinforce the need for developing new drug delivery systems. Mucoadhesive oral films (MOF) are promising dosage forms that adhere to the oral mucosa and deliver the drug through it, which present several advantages. These includebypassing the hepatic first pass effect, fast onset of action, ease of transportation and handling. The use of such dosage form is beneficial for drugs that have poor oral bioavailability and also for drugs that need to be rapidly absorbed.
According to Mr Accuracy reports’s new survey, global Mucoadhesive Oral Film market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Mucoadhesive Oral Film market research.
Key manufacturers engaged in the Mucoadhesive Oral Film industry include Aquestive Therapeutics, BioDelivery(BDSI), Kyukyu Pharmaceutical, Tapemark, Shilpa Therapeutics, IntelGenx, CL Pharm, Adhex Pharma and DK Livkon, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Mucoadhesive Oral Film were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Mucoadhesive Oral Film market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mucoadhesive Oral Film market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Aquestive Therapeutics
BioDelivery(BDSI)
Kyukyu Pharmaceutical
Tapemark
Shilpa Therapeutics
IntelGenx
CL Pharm
Adhex Pharma
DK Livkon
Arx Pharma
Aavishkar
ZIM Laboratories
Umang Pharmaceuticals
Segment by Type
Natural Polymer
Synthetic Polymer
Hospital and Clinic
Drug Store
E-commerce
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Mucoadhesive Oral Film report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Mucoadhesive Oral Film market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Mucoadhesive Oral Film market research.
Key manufacturers engaged in the Mucoadhesive Oral Film industry include Aquestive Therapeutics, BioDelivery(BDSI), Kyukyu Pharmaceutical, Tapemark, Shilpa Therapeutics, IntelGenx, CL Pharm, Adhex Pharma and DK Livkon, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Mucoadhesive Oral Film were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Mucoadhesive Oral Film market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mucoadhesive Oral Film market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Aquestive Therapeutics
BioDelivery(BDSI)
Kyukyu Pharmaceutical
Tapemark
Shilpa Therapeutics
IntelGenx
CL Pharm
Adhex Pharma
DK Livkon
Arx Pharma
Aavishkar
ZIM Laboratories
Umang Pharmaceuticals
Segment by Type
Natural Polymer
Synthetic Polymer
Segment by Application
Hospital and Clinic
Drug Store
E-commerce
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Mucoadhesive Oral Film report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source